A detailed history of True Mark Investments, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, True Mark Investments, LLC holds 2,735 shares of ABT stock, worth $355,632. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,735
Previous 11,904 77.02%
Holding current value
$355,632
Previous $1.62 Billion 77.37%
% of portfolio
0.06%
Previous 0.35%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 30, 2025

SELL
$120.51 - $136.62 $1.1 Million - $1.25 Million
-9,169 Reduced 77.02%
2,735 $366 Million
Q2 2025

Jul 29, 2025

BUY
$123.95 - $138.08 $1.48 Million - $1.64 Million
11,904 New
11,904 $1.62 Billion

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $228B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track True Mark Investments, LLC Portfolio

Follow True Mark Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True Mark Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True Mark Investments, LLC with notifications on news.